ArticleJournal of experimental & clinical cancer research : CR2019

Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation.

Ji-Chang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.